Hybridoma technology has been successfully used in

Hybridoma technology is a biotechnique used for producing large numbers of monoclonal antibodies using a hybridoma cell line that produced by fusing an antibodies-producing B cell and an immortal myeloma cell (cancer cell) to produce an immortal antibody-producing B Cell called a hybridoma cell.